enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Management of attention deficit hyperactivity disorder

   en.wikipedia.org/wiki/Management_of_attention...

   The extended release form has been approved by the FDA for the treatment of attention-deficit hyperactivity disorder (ADHD) in children as an alternative to stimulant medications. Its beneficial actions are likely due to its ability to strengthen prefrontal cortical regulation of attention and behavior. [95] Clonidine

3. List of investigational attention deficit hyperactivity ...

   en.wikipedia.org/wiki/List_of_investigational...

   This is a list of investigational attention deficit hyperactivity disorder drugs, or drugs that are currently under development for clinical use in the treatment of attention deficit hyperactivity disorder (ADHD) but are not yet approved. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in ...

4. Methylphenidate - Wikipedia

   en.wikipedia.org/wiki/Methylphenidate

   Methylphenidate, sold under the brand names Ritalin (/ ˈ r ɪ t ə l ɪ n / RIT-ə-lin) and Concerta (/ k ə n ˈ s ɜːr t ə / kən-SUR-tə) among others, is a central nervous system (CNS) stimulant indicated in the pharmacotherapy of attention deficit hyperactivity disorder (ADHD) and narcolepsy.

5. FDA Declares Adderall Shortage Following Supply Delays

   www.aol.com/fda-declares-adderall-shortage...

   The FDA recommended possible alternative treatments for those who need the medication until the shortage is resolved, such as extended-release versions of amphetamine mixed salts. The agency ...

6. High-dose ADHD drugs linked to 81% higher psychosis risk ...

   www.aol.com/high-dose-adhd-drugs-linked...

   High-dose ADHD drugs linked to 81% higher psychosis risk, study warns. Corrie Pelc. ... initiate treatment with extended-release formulations to minimize peak plasma levels, and emphasize ...

7. Guanfacine - Wikipedia

   en.wikipedia.org/wiki/Guanfacine

   Guanfacine, sold under the brand name Tenex (immediate-release) and Intuniv (extended-release) among others, is an oral alpha-2a agonist medication used to treat attention deficit hyperactivity disorder (ADHD) and high blood pressure. [3] [10] Common side effects include sleepiness, constipation, and dry mouth. [10]

8. ADHD drugs' impact on brain health, quality of life ... - AOL

   www.aol.com/adhd-drugs-impact-brain-health...

   ADHD medication tied to 19% lower death risk. An observational study conducted in Sweden, whose results appeared in JAMA in March 2024, further emphasized the positive impact of ADHD medication on ...

9. Dexmethylphenidate - Wikipedia

   en.wikipedia.org/wiki/Dexmethylphenidate

   CTx-1301 is an experimental medication that is an extended-release formulation of dexmethylphenidate that has a half life more than an hour longer than extended-release dexmethylphenidate (d-MPH-ER). It is under development for ADHD .